How has been the historical performance of Godavari Bioref.?

Answer:The historical performance of Godavari Bioref. shows a decline in key financial metrics over the past three years, particularly in profitability.

Breakdown:
In the fiscal year ending March 2025, Godavari Bioref. reported net sales of 1,870.25 crore, an increase from 1,686.67 crore in March 2024, but a decrease from 2,014.69 crore in March 2023. Total operating income mirrored this trend, reaching 1,870.25 crore in March 2025, up from 1,686.67 crore the previous year, yet down from 2,014.69 crore two years prior. The company's total expenditure, excluding depreciation, increased to 1,766.60 crore in March 2025 from 1,553.13 crore in March 2024, while operating profit (PBDIT) fell to 120.31 crore from 147.94 crore in the previous year. The profit before tax turned negative at -1.54 crore in March 2025, a significant drop from 12.45 crore in March 2024 and 31.75 crore in March 2023. Consequently, the profit after tax also declined sharply to -23.41 crore in March 2025, compared to 12.30 crore in March 2024 and 19.64 crore in March 2023. The earnings per share (EPS) reflected this downturn, falling to -4.57 in March 2025 from 2.93 in March 2024 and 4.68 in March 2023. Overall, the company's financial performance indicates a challenging period, with declining profitability and increased costs impacting its bottom line.